A topical therapeutic hydrophobic breakable composition includes a carrier comprising (a) about 60% to about 99% by weight of at least one hydrophobic oil; (b) at least one viscosity-modifying agents selected from the group consisting of a fatty alcohol, a fatty acid and a wax; and (c) a tetracycline antibiotic, characterized in that at least part of the tetracycline antibiotic is suspended in the composition; the viscosity of the composition is at least about 30% higher than the viscosity of the carrier without the tetracycline antibiotic; and is higher than the viscosity or the hydrophobic oil and the tetracycline antibiotic without the viscosity modifying agents. The tetracycline is chemically stable in the composition for at least six months; wherein more than about 90% of the tetracycline has not broken down. The composition is packaged as a breakable foam that breaks easily upon application of shear force.

The present invention relates to a method for preventing or treating disease in a mammal, particularly a human, by maintaining a fluoride free diet. Such diseases include autism, cancer, Alzheimer's disease, multiple sclerosis, calcification of the pineal gland, diabetes, depression, schizophrenia, psychotic diseases, muscular dystrophy, and others.

The present invention relates to a method for preventing or treating disease in a mammal, particularly a human, by maintaining a fluoride free diet. Such diseases include autism, cancer, Alzheimer's disease, multiple sclerosis, calcification of the pineal gland, diabetes, depression, schizophrenia, psychotic diseases, muscular dystrophy, and others.

The present invention relates to a cosmetic composition in the foam form comprising, in a physiologically acceptable medium, at least one aqueous phase, talc and one UV sunscreen ingredient. It also relates to a cosmetic composition in the foam form comprising, in a physiologically acceptable medium, at least one aqueous phase, at least 1% by weight of at least one mineral filler relative to its total weight, and one UV sunscreen ingredient.

A system is provided that includes a dispensing device configured to receive at least one cartridge that contains a cosmetic material and to dispense a specified amount of the cosmetic material from the cartridge into a receiving area, the at least one cartridge including an electronic communication and storage device configured to store data regarding the cosmetic material stored in the cartridge. The system includes a mobile user device configured to perform communication with the dispensing assembly to receive information related to the data stored on the electronic communication and storage device and to transmit a command to cause the dispensing assembly to dispense the specified amount of the cosmetic material. The electronic communication and storage device stores data regarding (i) a production process of the at least one cartridge that is created prior to the at least one cartridge initially being inserted into the dispensing device, and (ii) a usage of the at least one cartridge after the at least one cartridge is inserted into the dispensing device.

A topical therapeutic hydrophobic breakable composition includes a carrier comprising (a) about 60% to about 99% by weight of at least one hydrophobic oil; (b) at least one viscosity-modifying agents selected from the group consisting of a fatty alcohol, a fatty acid and a wax; and (c) a tetracycline antibiotic, characterized in that at least part of the tetracycline antibiotic is suspended in the composition; the viscosity of the composition is at least about 30% higher than the viscosity of the carrier without the tetracycline antibiotic; and is higher than the viscosity of the hydrophobic oil and the tetracycline antibiotic without the viscosity modifying agents. The tetracycline is chemically stable in the composition for at least six months; wherein more than about 90% of the tetracycline has not broken down. The composition is packaged as a breakable foam that breaks easily upon application of shear force.

The present invention provides a method for proposing personalized cosmetics and a system for implementing the same, the method comprising the steps of: photographing the visible spectrum of the skin of a subject to be measured; mapping a personalized visible spectrum to the measured visible spectrum of the skin so as to generate a spectral comparison table; matching a personalized composition to the spectral comparison table; and displaying the matched personalized composition on an image display unit.

The present invention provides a method for proposing personalized cosmetics and a system for implementing the same, the method comprising the steps of: photographing the visible spectrum of the skin of a subject to be measured; mapping a personalized visible spectrum to the measured visible spectrum of the skin so as to generate a spectral comparison table; matching a personalized composition to the spectral comparison table; and displaying the matched personalized composition on an image display unit.

A compound represented by the formula I ##STR00001##
R.sub.1 is (CHR.sub.4).sub.m(CHR.sub.5).sub.n(CHR.sub.6).sub.oCHO, with R.sub.4, R.sub.5, R.sub.6 being independently selected from H or Me, and with m, n, o being independently selected from 0 and 1; R.sub.2 is H or Me; and R.sub.3 is a C3-C6 branched, linear or cyclic alkenyl residue. Said compounds are useful as perfume ingredients in personal care and household care products.

The present invention is directed to an oral composition containing a gel network phase comprising: (i) one or more fatty amphiphiles, (ii) one or more surfactants, and (iii) one or more solvents; and an oral carrier phase. In certain embodiments, the gel network is used to structure the oral composition. The present invention is also directed to a method of forming an oral composition containing a gel network.